What human blood-brain barrier models can tell us about BBB function and drug discovery?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10316/92393 https://doi.org/10.1080/17460441.2019.1646722 |
Resumo: | Introduction: Human in vitro blood-brain barrier (BBB) models could be important tools for studying BBB development, maintenance and regulation. However, our capacity to obtain information from these models is still limited in part because only in recent years have (i) these models been derived from non-brain cell sources (e.g. stem cells), (ii) microfluidic systems been developed to recapitulate aspects of BBB physiology and (iii) new insights into the molecular and cellular mechanisms of BBB diseases (e.g. Huntington´s, Allan-Herndon-Dudley Syndrome) been described. Area covered: This article reviews the technological advances in the derivation of human cells from the neurovascular unit using stem cells and the creation of personalized BBB models generated from patients with neurodegenerative diseases. It also reviews the scientific advances generated from in vitro BBB models. Expert opinion: The recent technological advances in the derivation of human cells from the neurovascular unit from stem cells as well as in the generation of BBB-on-a-chip that recapitulate in vitro part of the BBB physiology are significant to generate more robust BBB models; however, a considerable effort is still needed to validate the potential of these models to recapitulate the in vivo cellular and molecular mechanisms, in particular regarding BBB function in health and disease. |
id |
RCAP_ca668c50232ce2c65ad59f9767d9b1be |
---|---|
oai_identifier_str |
oai:estudogeral.uc.pt:10316/92393 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
What human blood-brain barrier models can tell us about BBB function and drug discovery?BBB function; Blood-brain barrier (BBB); drug discovery; human models; stem cellsAnimalsBlood-Brain BarrierBrain DiseasesDrug DiscoveryHumansLab-On-A-Chip DevicesModels, BiologicalNeurodegenerative DiseasesStem CellsIntroduction: Human in vitro blood-brain barrier (BBB) models could be important tools for studying BBB development, maintenance and regulation. However, our capacity to obtain information from these models is still limited in part because only in recent years have (i) these models been derived from non-brain cell sources (e.g. stem cells), (ii) microfluidic systems been developed to recapitulate aspects of BBB physiology and (iii) new insights into the molecular and cellular mechanisms of BBB diseases (e.g. Huntington´s, Allan-Herndon-Dudley Syndrome) been described. Area covered: This article reviews the technological advances in the derivation of human cells from the neurovascular unit using stem cells and the creation of personalized BBB models generated from patients with neurodegenerative diseases. It also reviews the scientific advances generated from in vitro BBB models. Expert opinion: The recent technological advances in the derivation of human cells from the neurovascular unit from stem cells as well as in the generation of BBB-on-a-chip that recapitulate in vitro part of the BBB physiology are significant to generate more robust BBB models; however, a considerable effort is still needed to validate the potential of these models to recapitulate the in vivo cellular and molecular mechanisms, in particular regarding BBB function in health and disease.This work was funded by FEDER through the Program COMPETE and by Portuguese fund through FCT in context of the projects “AGING-MODEL” (Ref. POCI-01-0145- FEDER-029229) and “Unraveling the Rules of Passive Permeation Through the Blood-Brain Barrier” (Ref: PTDC/DTP-FTO/2784/2014), as well as the European project ERAatUC (ref. 669088). LF would like to thank Dr. Hugo Fernandes for the critical reading of the manuscriptTaylor & Francis2019info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/92393http://hdl.handle.net/10316/92393https://doi.org/10.1080/17460441.2019.1646722eng1746-04411746-045XFerreira, Linoinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-04-06T10:20:22Zoai:estudogeral.uc.pt:10316/92393Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:11:30.038542Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
What human blood-brain barrier models can tell us about BBB function and drug discovery? |
title |
What human blood-brain barrier models can tell us about BBB function and drug discovery? |
spellingShingle |
What human blood-brain barrier models can tell us about BBB function and drug discovery? Ferreira, Lino BBB function; Blood-brain barrier (BBB); drug discovery; human models; stem cells Animals Blood-Brain Barrier Brain Diseases Drug Discovery Humans Lab-On-A-Chip Devices Models, Biological Neurodegenerative Diseases Stem Cells |
title_short |
What human blood-brain barrier models can tell us about BBB function and drug discovery? |
title_full |
What human blood-brain barrier models can tell us about BBB function and drug discovery? |
title_fullStr |
What human blood-brain barrier models can tell us about BBB function and drug discovery? |
title_full_unstemmed |
What human blood-brain barrier models can tell us about BBB function and drug discovery? |
title_sort |
What human blood-brain barrier models can tell us about BBB function and drug discovery? |
author |
Ferreira, Lino |
author_facet |
Ferreira, Lino |
author_role |
author |
dc.contributor.author.fl_str_mv |
Ferreira, Lino |
dc.subject.por.fl_str_mv |
BBB function; Blood-brain barrier (BBB); drug discovery; human models; stem cells Animals Blood-Brain Barrier Brain Diseases Drug Discovery Humans Lab-On-A-Chip Devices Models, Biological Neurodegenerative Diseases Stem Cells |
topic |
BBB function; Blood-brain barrier (BBB); drug discovery; human models; stem cells Animals Blood-Brain Barrier Brain Diseases Drug Discovery Humans Lab-On-A-Chip Devices Models, Biological Neurodegenerative Diseases Stem Cells |
description |
Introduction: Human in vitro blood-brain barrier (BBB) models could be important tools for studying BBB development, maintenance and regulation. However, our capacity to obtain information from these models is still limited in part because only in recent years have (i) these models been derived from non-brain cell sources (e.g. stem cells), (ii) microfluidic systems been developed to recapitulate aspects of BBB physiology and (iii) new insights into the molecular and cellular mechanisms of BBB diseases (e.g. Huntington´s, Allan-Herndon-Dudley Syndrome) been described. Area covered: This article reviews the technological advances in the derivation of human cells from the neurovascular unit using stem cells and the creation of personalized BBB models generated from patients with neurodegenerative diseases. It also reviews the scientific advances generated from in vitro BBB models. Expert opinion: The recent technological advances in the derivation of human cells from the neurovascular unit from stem cells as well as in the generation of BBB-on-a-chip that recapitulate in vitro part of the BBB physiology are significant to generate more robust BBB models; however, a considerable effort is still needed to validate the potential of these models to recapitulate the in vivo cellular and molecular mechanisms, in particular regarding BBB function in health and disease. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10316/92393 http://hdl.handle.net/10316/92393 https://doi.org/10.1080/17460441.2019.1646722 |
url |
http://hdl.handle.net/10316/92393 https://doi.org/10.1080/17460441.2019.1646722 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
1746-0441 1746-045X |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Taylor & Francis |
publisher.none.fl_str_mv |
Taylor & Francis |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799134012051030016 |